Conjugated estrogens/medroxyprogesterone Interactions
There are 415 drugs known to interact with conjugated estrogens/medroxyprogesterone, along with 25 disease interactions, and 6 alcohol/food interactions. Of the total drug interactions, 60 are major, 334 are moderate, and 21 are minor.
- View all 415 medications that may interact with conjugated estrogens/medroxyprogesterone
- View conjugated estrogens/medroxyprogesterone alcohol/food interactions (6)
- View conjugated estrogens/medroxyprogesterone disease interactions (25)
Most frequently checked interactions
View interaction reports for conjugated estrogens / medroxyprogesterone and the medicines listed below.
- Actos (pioglitazone)
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Ambien (zolpidem)
- Amoxil (amoxicillin)
- Armour Thyroid (thyroid desiccated)
- Cardizem (diltiazem)
- Celexa (citalopram)
- Cipro (ciprofloxacin)
- Combivent (albuterol / ipratropium)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- DHEA (dehydroepiandrosterone)
- Diflucan (fluconazole)
- Elavil (amitriptyline)
- Estrace (estradiol)
- Flax Seed Oil (flax)
- Flomax (tamsulosin)
- Fosamax (alendronate)
- Lamictal (lamotrigine)
- Lasix (furosemide)
- Lunesta (eszopiclone)
- Lyrica (pregabalin)
- Paracetamol (acetaminophen)
- Sinemet (carbidopa / levodopa)
- Synthroid (levothyroxine)
- Topamax (topiramate)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Conjugated estrogens/medroxyprogesterone alcohol/food interactions
There are 6 alcohol/food interactions with conjugated estrogens / medroxyprogesterone.
Conjugated estrogens/medroxyprogesterone disease interactions
There are 25 disease interactions with conjugated estrogens / medroxyprogesterone which include:
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- bone mineral density
- menstrual bleeding
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
Report options
More about conjugated estrogens / medroxyprogesterone
- conjugated estrogens/medroxyprogesterone consumer information
- Compare alternatives
- Reviews (71)
- Side effects
- Dosage information
- During pregnancy
- Drug class: sex hormone combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
